CNPAX | MECVX | CNPAX / MECVX | |
Total Expense Ratio | 0.77 | 1.41 | 55% |
Annual Report Gross Expense Ratio | 0.77 | 1.41 | 55% |
Fund Existence | 24 years | 9 years | - |
Gain YTD | 15.189 | 8.112 | 187% |
Front Load | 4% | 5% | 70% |
Min. Initial Investment | 250 | 2500 | 10% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 159B | 143M | 111,189% |
Annual Yield % from dividends | 0.48 | 0.10 | 488% |
Returns for 1 year | 11.98 | 3.29 | 364% |
Returns for 3 years | 43.02 | 49.67 | 87% |
Returns for 5 years | 32.36 | 7.96 | 406% |
Returns for 10 years | 103.57 | N/A | - |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
WSTAX | 62.15 | 0.37 | +0.60% |
Macquarie Science and Technology A | |||
EMQAX | 9.26 | N/A | N/A |
Ashmore Emerging Markets Active Eq A | |||
IVSOX | 23.40 | N/A | N/A |
Voya SmallCap Opportunities Port I | |||
IUCEX | 28.47 | -0.01 | -0.04% |
JPMorgan International Focus C | |||
FCUPX | 20.55 | -0.01 | -0.05% |
NYLI PineStone U.S. Equity Class P |